← Back
$BBIO All transactions

BridgeBio Pharma, Inc.

▼ SELL

$ Value

$68K

Shares

1,542

Price

$44

Filed

Jun 30

Insider

Name

Valantine Hannah

Title

CIK

0001855608

Roles

Director

Transaction Details

Transaction Date

2025-06-26

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

7,465

Footnotes

Represents the weighted average sale price of the shares sold from $44.025 to $44.14 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. | Represents the weighted average sale price of the shares sold from $44.12 to $44.13 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

Filing Info

Accession No.

0000950170-25-091762

Form Type

4

Issuer CIK

0001743881

Valantine Hannah's History

Date Ticker Type Value
2025-11-12 BBIO M $1.2M
2025-11-12 BBIO $1.7M
2025-11-12 BBIO M $0
2025-06-26 BBIO $39K
2025-06-26 BBIO $68K
2025-06-26 BBIO $18K
2025-06-26 BBIO $83K
2025-06-20 BBIO A $0
2025-06-20 BBIO A $0
2025-06-18 CDNA $203K

Other Insiders at BBIO (90d)

Insider Bought Sold Last
Kumar Neil
Chief Executive Officer
$6.0M 2026-04-10